AlternativeMed
ancient wisdom · Remedy

Guizhi Fuling Capsule; Gui Zhi Fu Ling Capsule

Guizhi Fuling Capsule; Gui Zhi Fu Ling Capsule. Chinese patent medicines. For: It is used for women with symptoms caused by blood stasis, amenorrhea, dysmenorrhea, postpartum lochia; uterine fibroids, chronic pelvic inflammatory masses, dysmenorrhea, endometriosis, ovarian

📜 Names
Pinyin Name
Guizhi Fuling Jiaonang
中文名 (Chinese)
桂枝茯苓胶囊
English Name
Guizhi Fuling Capsule; Gui Zhi Fu Ling Capsule
💊 Form & Use
Category
Chinese patent medicines
Dosage Form
胶囊剂 (Capsule)
Administration
Oral
Source / 出处
Chinese Pharmacopoeia 2020 edition
🌿 Composition — Clickable herb chips
🩺 Syndromes & Indications
Syndromes (中文)
活血,化瘀,消癥
Indications (中文)
用于妇人瘀血阻络所致癥块、经闭、痛经、产后恶露不尽;子宫肌瘤,慢性盆腔炎包块,痛经,子宫内膜异位症,卵巢囊肿见上述证候者;也可用于女性乳腺囊性增生病属瘀血阻络证,症见乳房疼痛、乳房肿块、胸胁胀闷;或用于前列腺增生属瘀阻膀胱证,症见小便不爽、尿细如线、或点滴而下、小腹胀痛者
Indications (English)
It is used for women with symptoms caused by blood stasis, amenorrhea, dysmenorrhea, postpartum lochia; uterine fibroids, chronic pelvic inflammatory masses, dysmenorrhea, endometriosis, ovarian cysts with the above symptoms; It can also be used for female cystic hyperplasia of breast, which is a syndrome of blood stasis and collaterals, such as breast pain, breast lumps, chest and hypotension, or for prostate hyperplasia, which is a syndrome of stasis and bladder. Or dripping, lower abdomen pai
0
Clinical Trials
6
Meta-Analyses
2
PubMed References
📋 Sample Trials
None linked yet.
📊 Sample Meta-Analyses
CRD42021258868
Network meta-analysis of six kinds of Chinese patent medicines combined with mifepristone in the treatment of uterine fibroids: a protocol for systematic review and network meta-analysis
Uterine fibroids is a benign tumor, which belongs to the category of ' abdominal
CRD42022378316
Network Meta-analysis of five peroral Chinese patent medicines combined with conventional western medicine in treatment of uterine fibroid.
Uterine fibroid is a benign tumor of the female reproductive system, which is re
CRD42020147184
Efficacy and safety of Chinese patent medicines Guizhi Fuling Capsule and Guizhi Fuling Pill on treating adenomyosis: protocol for a systematic review and meta-analysis of randomized controlled trials
Adenomyosis is a commonly diagnosed estrogen-dependent gynecological disorder th
CRD42020169856
Adjuvant Treatment with Guizhi Fuling Capsule/Pill for Women with Polycystic Ovarian syndrome : A Meta-Analysis
Polycystic Ovarian Syndrome; Herbal medicine; Guizhi Fuling Capsule / Pill
CRD42022326351
The Efficacy and Safety of Chinese Herbal Medicine Guizhi Fuling Capsule Combined With Mifepristone in the Treatment of Uterine Fibroids: A Systematic Review and Meta-Analysis
Uterine fibroids (UF) are the most common benign uterine neoplasms and are most
CRD42022354530
Add-on effect of Guizhi Fuling Formula for treating infertility induced by polycystic ovary syndrome: a meta-analysis of randomized controlled trials
Polycystic ovary syndrome (PCOS) is a hormonal disorder common among reproductiv
📚 Sample References
PMID 33746752
Deciphering the Pharmacological Mechanisms of Guizhi-Fuling Capsule on Primary Dysmenorrhea Through Network Pharmacology
Front Pharmacol · 2021
PMID 35181487
Guizhi Fuling Capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/β-Catenin signaling pathway
J Ethnopharmacol · 2022
🏥 Indications — click any to find related diseases